Related references
Note: Only part of the references are listed.Formononetin promotes proliferation that involves a feedback loop of microRNA-375 and estrogen receptor alpha in estrogen receptor-positive cells
Jian Chen et al.
MOLECULAR CARCINOGENESIS (2016)
Frequent down-regulation of ABC transporter genes in prostate cancer
Rita Demidenko et al.
BMC CANCER (2015)
Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker
Thalia Erbes et al.
BMC CANCER (2015)
Exosomal miR-1290 and miR-375 as Prognostic Markers in Castration-resistant Prostate Cancer
Xiaoyi Huang et al.
EUROPEAN UROLOGY (2015)
Diagnostic Performance of Expression of PCA3, Hepsin and miR Biomarkers Inejaculate in Combination With Serum PSA for the Detection of Prostate Cancer
Matthew J. Roberts et al.
PROSTATE (2015)
Identification of microRNAs differentially expressed in prostatic secretions of patients with prostate cancer
Esra Guzel et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Biomarkers for determination prostate cancer: implication for diagnosis and prognosis
S. Ziaran et al.
NEOPLASMA (2015)
Urinary MicroRNAs of Prostate Cancer: Virus-Encoded hsv1-miR-H18 and hsv2-miR-H9-5p Could Be Valuable Diagnostic Markers
Seok Joong Yun et al.
INTERNATIONAL NEUROUROLOGY JOURNAL (2015)
MicroRNA in prostate cancer: functional importance and potential as circulating biomarkers
Benjamin L. Jackson et al.
BMC CANCER (2014)
Clinical use of novel urine and blood based prostate cancer biomarkers: A review
S. Dijkstra et al.
CLINICAL BIOCHEMISTRY (2014)
Human seminal fluid as a source of prostate cancer-specific microRNA biomarkers
Luke A. Selth et al.
ENDOCRINE-RELATED CANCER (2014)
Prognostic Value of RASSF1 Promoter Methylation in Prostate Cancer
Kristina Daniunaite et al.
JOURNAL OF UROLOGY (2014)
miR-34a is an Intracellular and Exosomal Predictive Biomarker for Response to Docetaxel with Clinical Relevance to Prostate Cancer Progression
Claire Corcoran et al.
PROSTATE (2014)
Urine microRNAs as potential noninvasive biomarkers in urologic cancers
Hana Mlcochova et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2014)
Serum microRNA expression patterns that predict early treatment failure in prostate cancer patients
Prashant K. Singh et al.
ONCOTARGET (2014)
Potential Urinary miRNA Biomarker Candidates for the Accurate Detection of Prostate Cancer among Benign Prostatic Hyperplasia Patients
Taha A. Haj-Ahmad et al.
JOURNAL OF CANCER (2014)
A review of expression profiling of circulating microRNAs in men with prostate cancer
Brian D. Kelly et al.
BJU INTERNATIONAL (2013)
Circulating microRNAs as potential new biomarkers for prostate cancer
A. Sita-Lumsden et al.
BRITISH JOURNAL OF CANCER (2013)
Current Status of Biomarkers for Prostate Cancer
Vicki M. Velonas et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Circulating microRNA Profiling Identifies a Subset of Metastatic Prostate Cancer Patients with Evidence of Cancer-Associated Hypoxia
Heather H. Cheng et al.
PLOS ONE (2013)
Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and low-risk, localized prostate cancer
Han Christine Ngoc Nguyen et al.
PROSTATE (2013)
Changes in circulating microRNA levels associated with prostate cancer
R. J. Bryant et al.
BRITISH JOURNAL OF CANCER (2012)
Combined analysis of TMPRSS2-ERG and TERT for improved prognosis of biochemical recurrence in prostate cancer
Rasa Sabaliauskaite et al.
GENES CHROMOSOMES & CANCER (2012)
Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease
Luke A. Selth et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
MicroRNA profiles of prostate carcinoma detected by multiplatform microRNA screening
Sven Wach et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer
S. E. Jalava et al.
ONCOGENE (2012)
Circulating miRNAs are correlated with tumor progression in prostate cancer
Jan C. Brase et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
MicroRNAs in body fluids-the mix of hormones and biomarkers
Maria Angelica Cortez et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
The MicroRNA Spectrum in 12 Body Fluids
Jessica A. Weber et al.
CLINICAL CHEMISTRY (2010)
Prostate cancer incidence and mortality trends in 37 European countries: An overview
F. Bray et al.
EUROPEAN JOURNAL OF CANCER (2010)
MiR-148a Attenuates Paclitaxel Resistance of Hormone-refractory, Drug-resistant Prostate Cancer PC3 Cells by Regulating MSK1 Expression.
Yasunori Fujita et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
The MicroRNA Profile of Prostate Carcinoma Obtained by Deep Sequencing
Jaroslaw Szczyrba et al.
MOLECULAR CANCER RESEARCH (2010)
miR-148a is an androgen-responsive microRNA that promotes LNCaP prostate cell growth by repressing its target CAND1 expression
T. Murata et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2010)
DNA Methylation Biomarkers of Prostate Cancer: Confirmation of Candidates and Evidence Urine is the Most Sensitive Body Fluid for Non-Invasive Detection
Shannon R. Payne et al.
PROSTATE (2009)
Genomic profiling of MicroRNA and messenger RNA reveals deregulated MicroRNA expression in prostate cancer
Stefan Ambs et al.
CANCER RESEARCH (2008)
被撤回的出版物: MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer (Retracted article. See vol. 175, pg. 192, 2023)
Douglas D. Taylor et al.
GYNECOLOGIC ONCOLOGY (2008)
Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues
E. Bandres et al.
MOLECULAR CANCER (2006)
The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma
JI Epstein et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2005)
Share Paper
